Is it clinically and epidemiologically sound, and economically effective, to switch the range of surgical gloves to latex-free products? The new study The Latex-Free Hospital examines the extent to which switching the glove portfolio to latex-free products is clinically, epidemiologically and economically justifiable. Latex sensitivity and latex-allergic reactions continue to represent a significant burden on the healthcare system that should not be underestimated. Staff in healthcare facilities are at particular risk of developing latex-associated allergies due to their regular contact with medical devices containing latex. The regular wearing of latex gloves is considered the most common cause of latex allergies. The prevalence of latex sensitivity amongst staff in healthcare facilities ranges between 8 and 12 per cent; for staff in the operating theatre, the risk rises to as high as 15 per cent. In the general population, the prevalence of latex sensitivity is estimated at 1 to 2 per cent.
The creation of a latex-free environment in hospitals, particularly in high-care areas such as operating theatres, intensive care units, A&E departments or oncology wards, is the subject of heated debate amongst clinical professionals, infection control experts and procurement managers. From the perspective of purchasers, this controversy is reflected, amongst other things, in the procurement of latex-free gloves. Against this backdrop of a controversial debate, this study aims to assess the practicality, necessity and cost-effectiveness of a switch to the primary use of latex-free gloves from the perspective of purchasers and logistics specialists.
The full results of the survey are available for free download here.